Cargando…
Synthesis of protective oral PrEP adherence levels in cisgender women using convergent clinical- and bottom-up modeling
Globally, most HIV infections occur in heterosexual women in resource-limited settings. In these settings, female self-protection with generic emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis (FTC/TDF-PrEP) may constitute a major pillar of the HIV prevention portfolio. However, c...
Autores principales: | Zhang, Lanxin, Iannuzzi, Sara, Chaturvedula, Ayyappa, Haberer, Jessica E., Hendrix, Craig W., von Kleist, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153398/ https://www.ncbi.nlm.nih.gov/pubmed/37131701 http://dx.doi.org/10.21203/rs.3.rs-2772765/v1 |
Ejemplares similares
-
Model-based predictions of protective HIV pre-exposure prophylaxis adherence levels in cisgender women
por: Zhang, Lanxin, et al.
Publicado: (2023) -
“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021) -
Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value
por: Abaasa, Andrew, et al.
Publicado: (2017) -
979. Disparities in PrEP uptake and adherence among cisgender women using a pharmacologic measure
por: Hebel, Shane, et al.
Publicado: (2020) -
“PrEP’s just to secure you like insurance”: a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi
por: Willie, Tiara C., et al.
Publicado: (2021)